docetaxel anhydrous has been researched along with Monosomy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casorzo, L; Montemurro, F; Redana, S; Risio, M | 1 |
1 other study(ies) available for docetaxel anhydrous and Monosomy
Article | Year |
---|---|
HER2 gene-amplified breast cancers with monosomy of chromosome 17 are poorly responsive to trastuzumab-based treatment.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 17; Disease Progression; Docetaxel; Female; Genes, erbB-2; Humans; Middle Aged; Monosomy; Taxoids; Time Factors; Trastuzumab | 2005 |